| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SHARIR DAFNA | Director | C/O ORMAT TECHNOLOGIES, INC., 6884 SIERRA CENTER PARKWAY, RENO | /s/ Jessica Woelfel - as attorney-in-fact | 24 Jun 2025 | 0001181711 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ORA | Common Stock | Options Exercise | $93,013 | +1,210 | +27% | $76.87 | 5,648 | 20 Jun 2025 | Direct | F1 |
| transaction | ORA | Common Stock | Disposed to Issuer | $92,957 | -1,089 | -19% | $85.36 | 4,559 | 20 Jun 2025 | Direct | F1 |
| transaction | ORA | Common Stock | Sale | $10,366 | -121 | -2.7% | $85.67 | 4,438 | 20 Jun 2025 | Direct | F1 |
| transaction | ORA | Common Stock | Options Exercise | $88,815 | +1,315 | +30% | $67.54 | 5,753 | 20 Jun 2025 | Direct | F2 |
| transaction | ORA | Common Stock | Disposed to Issuer | $88,782 | -1,035 | -18% | $85.78 | 4,718 | 20 Jun 2025 | Direct | F2 |
| transaction | ORA | Common Stock | Sale | $24,027 | -280 | -5.9% | $85.81 | 4,438 | 20 Jun 2025 | Direct | F2 |
| transaction | ORA | Common Stock | Sale | $102,696 | -1,200 | -27% | $85.58 | 3,238 | 20 Jun 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ORA | Stock Appreciation Rights (SARS) | Options Exercise | $0 | -1,210 | -100% | $0.000000 | 0 | 20 Jun 2025 | Common Stock | 1,210 | $76.87 | Direct | |
| transaction | ORA | Stock Appreciation Rights (SARS) | Options Exercise | $0 | -1,315 | -100% | $0.000000 | 0 | 20 Jun 2025 | Common Stock | 1,315 | $67.54 | Direct |
| Id | Content |
|---|---|
| F1 | Represents the exercise of Stock Appreciation Rights (SARS) expiring on November 06, 2025, for which the reporting person exercised all 1,210 shares, disposed of 1,089 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 121 shares acquired upon exercise in the open market on June 20, 2025. Each SAR represents the right to receive shares of ORA common stock with a value equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised. |
| F2 | Represents the exercise of SARS expiring on November 04, 2026, for which the reporting person exercised all 1,315 shares, disposed of 1,035 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 280 shares in the open market on June 20, 2025. |
| F3 | Represents shares of common stock sold in the open market on June 20, 2025. |